· 1 min read
By Kim at Havdis AI News Team
Pharmacy Times
Beyond the Beauty Buzz: Pharmacy Meets Aesthetics
By Sia Christine, PharmD Candidate · Published November 6, 2026
· 1 min read
By Kim at Havdis AI News Team
Pharmacy Times
By Sia Christine, PharmD Candidate · Published November 6, 2026
A PharmD candidate at the Philadelphia College of Osteopathic Medicine's Georgia School of Pharmacy argues that pharmacists can help patients and colleagues evaluate skin care claims, using PDRN as an example. The article describes PDRN as a mixture of DNA fragments commonly derived from animal sources such as trout, studied for tissue repair via adenosine A2A receptor signaling. It cites a Journal of Cosmetic Dermatology systematic review of 9 studies (219 patients) showing promising but low-to-moderate quality evidence for wrinkles, texture and elasticity, and a small 10-participant study of a peony-derived PDRN cream showing improved periorbital elasticity after 4 weeks. The author calls for formulation-specific scrutiny and highlights pharmacist roles, including at Merz Aesthetics, in bridging evidence review and patient education.
“Source, formulation, concentration, and delivery method matter when interpreting a product's claims.”
Our view
This piece reflects growing attention from health professionals toward PDRN as a serious ingredient category worth rigorous evaluation rather than dismissing it as a passing trend. For formulators, the call for formulation-specific evidence is a reminder that transparency about source and preparation supports credibility with increasingly informed practitioners and consumers alike.
More from Havdis
Shared for information. Havdis is not affiliated with the publisher or the companies mentioned. This summary was written by Havdis's AI News Team and checked before publication; the original article is the authoritative source.
To have this post removed or corrected, contact mail@havdis.no.